nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—ALB—chronic obstructive pulmonary disease	0.713	1	CbGaD
Fospropofol—Pulmonary function test decreased—Aminophylline—chronic obstructive pulmonary disease	0.00751	0.0513	CcSEcCtD
Fospropofol—Respiratory depression—Aminophylline—chronic obstructive pulmonary disease	0.00751	0.0513	CcSEcCtD
Fospropofol—Propofol—CYP1A1—chronic obstructive pulmonary disease	0.0059	0.397	CrCbGaD
Fospropofol—Propofol—CYP1A2—chronic obstructive pulmonary disease	0.00569	0.382	CrCbGaD
Fospropofol—Ventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00534	0.0364	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—MMP14—chronic obstructive pulmonary disease	0.00515	0.0409	CbGpPWpGaD
Fospropofol—ALPL—Endochondral Ossification—TGFB2—chronic obstructive pulmonary disease	0.0043	0.0342	CbGpPWpGaD
Fospropofol—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00384	0.0262	CcSEcCtD
Fospropofol—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—chronic obstructive pulmonary disease	0.00375	0.0298	CbGpPWpGaD
Fospropofol—Propofol—ALB—chronic obstructive pulmonary disease	0.00329	0.221	CrCbGaD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00314	0.0214	CcSEcCtD
Fospropofol—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00297	0.0203	CcSEcCtD
Fospropofol—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00294	0.0201	CcSEcCtD
Fospropofol—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.00288	0.0196	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00261	0.0178	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—PLAU—chronic obstructive pulmonary disease	0.00244	0.0194	CbGpPWpGaD
Fospropofol—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00243	0.0166	CcSEcCtD
Fospropofol—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00241	0.0165	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—NOS2—chronic obstructive pulmonary disease	0.00219	0.0174	CbGpPWpGaD
Fospropofol—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00204	0.0139	CcSEcCtD
Fospropofol—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00198	0.0135	CcSEcCtD
Fospropofol—GABRG3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00197	0.0157	CbGpPWpGaD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00197	0.0135	CcSEcCtD
Fospropofol—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00195	0.0133	CcSEcCtD
Fospropofol—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00195	0.0133	CcSEcCtD
Fospropofol—GABRB1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00194	0.0154	CbGpPWpGaD
Fospropofol—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00192	0.0131	CcSEcCtD
Fospropofol—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00191	0.013	CcSEcCtD
Fospropofol—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0019	0.0129	CcSEcCtD
Fospropofol—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00189	0.0129	CcSEcCtD
Fospropofol—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00187	0.0127	CcSEcCtD
Fospropofol—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.0126	CcSEcCtD
Fospropofol—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00185	0.0126	CcSEcCtD
Fospropofol—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00184	0.0126	CcSEcCtD
Fospropofol—GABRA6—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00184	0.0146	CbGpPWpGaD
Fospropofol—GABRA4—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00182	0.0144	CbGpPWpGaD
Fospropofol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.0123	CcSEcCtD
Fospropofol—ALPL—AGE/RAGE pathway—NOS3—chronic obstructive pulmonary disease	0.00176	0.014	CbGpPWpGaD
Fospropofol—GABRG3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00176	0.014	CbGpPWpGaD
Fospropofol—GABRB1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00173	0.0137	CbGpPWpGaD
Fospropofol—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00171	0.0117	CcSEcCtD
Fospropofol—GABRB2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00166	0.0132	CbGpPWpGaD
Fospropofol—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.0112	CcSEcCtD
Fospropofol—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.0112	CcSEcCtD
Fospropofol—Cough—Formoterol—chronic obstructive pulmonary disease	0.00164	0.0112	CcSEcCtD
Fospropofol—GABRA6—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00164	0.013	CbGpPWpGaD
Fospropofol—GABRA4—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00162	0.0128	CbGpPWpGaD
Fospropofol—GABRA5—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00161	0.0128	CbGpPWpGaD
Fospropofol—Cough—Montelukast—chronic obstructive pulmonary disease	0.00161	0.011	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.0109	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00159	0.0109	CcSEcCtD
Fospropofol—GABRA3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00158	0.0126	CbGpPWpGaD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00156	0.0106	CcSEcCtD
Fospropofol—GABRA2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00156	0.0124	CbGpPWpGaD
Fospropofol—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.0106	CcSEcCtD
Fospropofol—GABRB3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00155	0.0123	CbGpPWpGaD
Fospropofol—GABRG2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00152	0.0121	CbGpPWpGaD
Fospropofol—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00151	0.0103	CcSEcCtD
Fospropofol—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.0103	CcSEcCtD
Fospropofol—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00149	0.0102	CcSEcCtD
Fospropofol—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.0102	CcSEcCtD
Fospropofol—GABRB2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00148	0.0117	CbGpPWpGaD
Fospropofol—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00148	0.0101	CcSEcCtD
Fospropofol—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00998	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—MMP9—chronic obstructive pulmonary disease	0.00145	0.0115	CbGpPWpGaD
Fospropofol—GABRA5—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00144	0.0114	CbGpPWpGaD
Fospropofol—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.0098	CcSEcCtD
Fospropofol—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00144	0.0098	CcSEcCtD
Fospropofol—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00975	CcSEcCtD
Fospropofol—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00971	CcSEcCtD
Fospropofol—GABRA3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00141	0.0112	CbGpPWpGaD
Fospropofol—ALPL—AGE/RAGE pathway—MMP9—chronic obstructive pulmonary disease	0.00141	0.0112	CbGpPWpGaD
Fospropofol—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00962	CcSEcCtD
Fospropofol—GABRA2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00139	0.011	CbGpPWpGaD
Fospropofol—GABRB3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00138	0.0109	CbGpPWpGaD
Fospropofol—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00136	0.00925	CcSEcCtD
Fospropofol—GABRG2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00135	0.0107	CbGpPWpGaD
Fospropofol—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00922	CcSEcCtD
Fospropofol—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00919	CcSEcCtD
Fospropofol—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00133	0.0105	CbGpPWpGaD
Fospropofol—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00905	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00905	CcSEcCtD
Fospropofol—Pain—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00897	CcSEcCtD
Fospropofol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00897	CcSEcCtD
Fospropofol—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00889	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00887	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—VEGFA—chronic obstructive pulmonary disease	0.0013	0.0103	CbGpPWpGaD
Fospropofol—Pain—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00878	CcSEcCtD
Fospropofol—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00128	0.00876	CcSEcCtD
Fospropofol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00863	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00855	CcSEcCtD
Fospropofol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00847	CcSEcCtD
Fospropofol—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00826	CcSEcCtD
Fospropofol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00818	CcSEcCtD
Fospropofol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.00814	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—TGFB1—chronic obstructive pulmonary disease	0.00119	0.00946	CbGpPWpGaD
Fospropofol—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00118	0.00939	CbGpPWpGaD
Fospropofol—ALPL—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	0.00114	0.00905	CbGpPWpGaD
Fospropofol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00772	CcSEcCtD
Fospropofol—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00742	CcSEcCtD
Fospropofol—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00742	CcSEcCtD
Fospropofol—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00727	CcSEcCtD
Fospropofol—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00701	CcSEcCtD
Fospropofol—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000977	0.00667	CcSEcCtD
Fospropofol—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000977	0.00667	CcSEcCtD
Fospropofol—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000965	0.00766	CbGpPWpGaD
Fospropofol—Headache—Formoterol—chronic obstructive pulmonary disease	0.000962	0.00657	CcSEcCtD
Fospropofol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000962	0.00657	CcSEcCtD
Fospropofol—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000957	0.00653	CcSEcCtD
Fospropofol—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00095	0.00755	CbGpPWpGaD
Fospropofol—Headache—Montelukast—chronic obstructive pulmonary disease	0.000943	0.00643	CcSEcCtD
Fospropofol—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000922	0.0063	CcSEcCtD
Fospropofol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000912	0.00623	CcSEcCtD
Fospropofol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000912	0.00623	CcSEcCtD
Fospropofol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000909	0.0062	CcSEcCtD
Fospropofol—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000899	0.00714	CbGpPWpGaD
Fospropofol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000894	0.0061	CcSEcCtD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000888	0.00705	CbGpPWpGaD
Fospropofol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000862	0.00588	CcSEcCtD
Fospropofol—ALB—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.000834	0.00662	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000812	0.00645	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000789	0.00626	CbGpPWpGaD
Fospropofol—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000787	0.00624	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000775	0.00615	CbGpPWpGaD
Fospropofol—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000775	0.00615	CbGpPWpGaD
Fospropofol—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000772	0.00527	CcSEcCtD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000761	0.00605	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000756	0.00601	CbGpPWpGaD
Fospropofol—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000747	0.0051	CcSEcCtD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000743	0.0059	CbGpPWpGaD
Fospropofol—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000733	0.00582	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000725	0.00576	CbGpPWpGaD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000724	0.00575	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000715	0.00567	CbGpPWpGaD
Fospropofol—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000711	0.00486	CcSEcCtD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000687	0.00545	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.000678	0.00539	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000676	0.00537	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000676	0.00537	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000668	0.0053	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000662	0.00526	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000649	0.00515	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000643	0.00511	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00064	0.00508	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000632	0.00502	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000632	0.00501	CbGpPWpGaD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000626	0.00428	CcSEcCtD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000621	0.00493	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000617	0.0049	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000612	0.00486	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000611	0.00485	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000606	0.00481	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000603	0.00479	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000593	0.00471	CbGpPWpGaD
Fospropofol—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000593	0.00405	CcSEcCtD
Fospropofol—GABRG3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000591	0.00469	CbGpPWpGaD
Fospropofol—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000587	0.00401	CcSEcCtD
Fospropofol—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000582	0.00462	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000582	0.00462	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000578	0.00459	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000572	0.00454	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00057	0.00453	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000569	0.00451	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000563	0.00447	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000561	0.00446	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.00056	0.00444	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000558	0.00443	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000556	0.00441	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000551	0.00438	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000551	0.00438	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000547	0.00435	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000544	0.00432	CbGpPWpGaD
Fospropofol—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000543	0.00371	CcSEcCtD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000542	0.0043	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000539	0.00428	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000538	0.00427	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000529	0.0042	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000529	0.0042	CbGpPWpGaD
Fospropofol—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000521	0.00356	CcSEcCtD
Fospropofol—GABRA6—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000518	0.00411	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000515	0.00409	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000512	0.00406	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0005	0.00397	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000498	0.00395	CbGpPWpGaD
Fospropofol—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000494	0.00337	CcSEcCtD
Fospropofol—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000491	0.0039	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000488	0.00388	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000484	0.00384	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000483	0.00383	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00048	0.00381	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000475	0.00377	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000471	0.00374	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000468	0.00371	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000467	0.0037	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000464	0.00368	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000462	0.00367	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000455	0.00362	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000455	0.00361	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000454	0.00361	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000453	0.0036	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000446	0.00354	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000446	0.00354	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000439	0.00348	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000436	0.00346	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000428	0.0034	CbGpPWpGaD
Fospropofol—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000428	0.00292	CcSEcCtD
Fospropofol—GABRA6—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000422	0.00335	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000417	0.00331	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000414	0.00329	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000412	0.00327	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.0004	0.00317	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000398	0.00316	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000395	0.00313	CbGpPWpGaD
Fospropofol—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000384	0.00262	CcSEcCtD
Fospropofol—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000381	0.00303	CbGpPWpGaD
Fospropofol—Headache—Prednisone—chronic obstructive pulmonary disease	0.000379	0.00259	CcSEcCtD
Fospropofol—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000374	0.00297	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00037	0.00294	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000364	0.00289	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000362	0.00287	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000361	0.00286	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000359	0.00285	CbGpPWpGaD
Fospropofol—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00245	CcSEcCtD
Fospropofol—GABRA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000358	0.00284	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000355	0.00282	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000349	0.00277	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000342	0.00272	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00032	0.00254	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000305	0.00242	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000294	0.00234	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000264	0.0021	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00025	0.00199	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.00024	0.0019	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000236	0.00187	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000226	0.00179	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000221	0.00176	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.00019	0.00151	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000189	0.0015	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000184	0.00146	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000184	0.00146	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000184	0.00146	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000165	0.00131	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000159	0.00127	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.000158	0.00125	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.00015	0.00119	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000149	0.00119	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000146	0.00116	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000146	0.00116	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000137	0.00109	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000135	0.00107	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	0.000133	0.00106	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000133	0.00105	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000131	0.00104	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000126	0.000997	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000124	0.000984	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000119	0.000942	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000113	0.0009	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000111	0.000882	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00011	0.000874	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.000108	0.000861	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000108	0.000861	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000108	0.000859	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	0.000108	0.000854	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000106	0.000844	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000106	0.000838	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000104	0.000823	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.000103	0.00082	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	0.000101	0.000802	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	9.95e-05	0.00079	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	9.56e-05	0.000759	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	9.52e-05	0.000756	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	9.48e-05	0.000753	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	9.47e-05	0.000752	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.06e-05	0.000719	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	8.75e-05	0.000695	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	8.61e-05	0.000684	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	8.22e-05	0.000652	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.09e-05	0.000642	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.97e-05	0.000632	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	7.68e-05	0.00061	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.54e-05	0.000598	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.44e-05	0.000591	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	7.37e-05	0.000585	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.2e-05	0.000572	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	6.99e-05	0.000555	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	6.95e-05	0.000552	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.81e-05	0.00054	CbGpPWpGaD
Fospropofol—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.69e-05	0.000531	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	6.64e-05	0.000527	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.63e-05	0.000527	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.61e-05	0.000525	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GC—chronic obstructive pulmonary disease	6.51e-05	0.000517	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.49e-05	0.000516	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.38e-05	0.000507	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.34e-05	0.000503	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.23e-05	0.000494	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.05e-05	0.00048	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.44e-05	0.000432	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.19e-05	0.000412	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.82e-05	0.000383	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	4.81e-05	0.000382	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	4.75e-05	0.000377	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	4.66e-05	0.00037	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	4.42e-05	0.000351	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	4.28e-05	0.00034	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	3.61e-05	0.000286	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.55e-05	0.000282	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	3.51e-05	0.000279	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	3.44e-05	0.000273	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	3.21e-05	0.000255	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.95e-05	0.000235	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	2.48e-05	0.000197	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.46e-05	0.000196	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.43e-05	0.000193	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	2.28e-05	0.000181	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.26e-05	0.00018	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.15e-05	0.00017	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.87e-05	0.000149	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	1.4e-05	0.000111	CbGpPWpGaD
